- Report
- January 2021
- 144 Pages
China, Global
From €3000EUR$3,324USD£2,649GBP
- Report
- January 2021
- 141 Pages
China, Global
From €3000EUR$3,324USD£2,649GBP
Cefotiam is an antibiotic belonging to the cephalosporin class of drugs. It is used to treat a variety of bacterial infections, including skin and soft tissue infections, respiratory tract infections, and urinary tract infections. Cefotiam is available in both oral and injectable forms. It is generally well tolerated, with few side effects.
Cefotiam is a widely used antibiotic in the global market. It is available in many countries, including the United States, Canada, Europe, and Asia. It is commonly prescribed for a variety of bacterial infections, and is often used in combination with other antibiotics.
The cefotiam market is highly competitive, with many companies offering their own versions of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and AstraZeneca. Show Less Read more